Publicacións en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (27)

2024

  1. Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure

    CardioRenal Medicine, Vol. 14, Núm. 1, pp. 261-269

2023

  1. Assessment of filling pressures and fluid overload in heart failure: an updated perspective

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 47-57

  2. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

    Scientific Reports, Vol. 13, Núm. 1

  3. Kidney function changes in acute heart failure: a practical approach to interpretation and management

    Clinical Kidney Journal, Vol. 16, Núm. 10, pp. 1587-1599

  4. Potential role of empagliflozin in myocardial iron repletion following ferric carboxymaltose for heart failure

    Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 121-123

  5. Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis

    Journal of Clinical Medicine, Vol. 12, Núm. 24

  6. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

    JACC: Heart Failure, Vol. 11, Núm. 11, pp. 1611-1622

  7. Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines

    Nutrients, Vol. 15, Núm. 7

2022

  1. Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure

    European Journal of Heart Failure, Vol. 24, Núm. 11, pp. 2108-2117

  2. Impact of an article in the social age: Is tweeting the same as citing?

    Nefrologia, Vol. 42, Núm. 2, pp. 125-129

  3. Long-Term Prognostic Impact of Estimated Glomerular Filtration Rate on Admission in Patients Hospitalized for Acute Heart Failure

    CardioRenal Medicine, Vol. 12, Núm. 4, pp. 179-188

  4. Potential role of empagliflozin in myocardial iron repletion following ferric carboxymaltose for heart failure

    Revista Espanola de Cardiologia

  5. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure

    European Journal of Internal Medicine, Vol. 95, pp. 67-73

  6. Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial

    European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826

  7. Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell

    Nefrologia, Vol. 42, Núm. 6, pp. 645-655

  8. The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease

    Journal of Clinical Medicine, Vol. 11, Núm. 14

2021

  1. CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 5, pp. 475-483

  2. Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 616-623

2020

  1. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

    American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4

  2. Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial

    Journal of the American Heart Association, Vol. 9, Núm. 4